South Africa is among 100 countries that received faulty cancer medication between 2018 and 2023, sparking alarm over patient safety. A study by the University of Notre Dame and the Bureau of Investigative Journalism revealed some chemotherapy drugs had dangerously low or excessively high levels of active ingredients. Although none of the South African samples were tested, 850 packages were distributed to local hospitals and pharmacies. Meanwhile Experts say cancer patients in the public sector in South Africa are dying for avoidable reasons like dysfunctional referral systems and a lack of medical imaging and treatment. We look at efforts to get the country's battle with cancer back on track. Bongiwe Zwane spoke to Zodwa Sithole head of advocacy at the Cancer Association of South Africa, CANSA